Research Summary: IMPROVEST® (gonadotropin releasing factor analog-diptheria toxoid conjugate) 0.2 mg/mL administration timing impacts performance outcomes in gilts
31 October 2022 4 minute read Recently, Zoetis was granted a label extension for the use of IMPROVEST for the ...